Volume 27, Number 3—March 2021
CME ACTIVITY - Research
Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
Table 2
MLST genotype | Fluconazole susceptibility | No. isolates tested | No. with echinocandin resistance | No. isolates with 5 Pdr1p AAS found in both FR and F-SDD isolates |
No. isolates with additional Pdr1p AAS except for 5 Pdr1p AAS |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
P76S | P143T | D243N | E259G | T745A | 1 | 2 | Total | |||||
ST7 | FR | 37 | 6† | 34 | 3 | 37 | ||||||
F-SDD |
98 |
3 |
0 |
0 |
||||||||
ST3 | FR | 7 | 0 | 7 | 7 | 7 | 6 | 1 | 7 | |||
F-SDD |
43 |
1 |
43 |
43 |
43 |
0 |
0 |
|||||
ST26 | FR | 7 | 0 | 6 | 6 | |||||||
F-SDD |
10 |
1 |
0 |
0 |
||||||||
ST22 | FR | 1 | 0 | 1 | 1 | |||||||
F-SDD |
16 |
1 |
0 |
0 |
||||||||
ST10 | FR | 2 | 0 | 2 | 2 | |||||||
F-SDD |
9 |
0 |
0 |
0 |
||||||||
ST55 | FR | 2 | 0 | 2 | 2 | 2 | ||||||
F-SDD |
6 |
1 |
6 |
1 |
1 |
|||||||
ST2 | FR | 2 | 0 | 2 | 2 | |||||||
F-SDD |
3 |
0 |
0 |
0 |
||||||||
ST6 | FR | 1 | 0 | 1 | 1 | |||||||
F-SDD |
5 |
2 |
0 |
0 |
||||||||
ST59 | FR | 1 | 0 | 1 | 1 | 1 | ||||||
F-SDD |
3 |
1 |
3 |
0 |
0 |
|||||||
ST1 |
FR |
2 |
0 |
2 |
2 |
|||||||
ST12 |
F-SDD |
2 |
0 |
0 |
0 |
|||||||
Other STs‡ |
FR | 4 | 0 | 1 | 2 | 2 | 4 | |||||
F-SDD |
17 |
0 |
2 |
2 |
2 |
1 |
1 |
|||||
Total, no. (%) | FR | 66 | 6 | 7 | 7 | 7 | 3 | 1 | 59 | 6§ | 65 (98.5) | |
F-SDD | 212 | 10 | 45 | 45 | 45 | 6 | 3 | 2¶ | 2 (0.9) |
*AAS, amino acid substitution; BSI, bloodstream infection; FR, fluconazole-resistant; F-SDD, fluconazole-susceptible dose-dependent; MLST, multilocus sequence typing; ST, sequence type. †All 6 isolates showed multidrug resistance, defined as resistance to both fluconazole and echinocandins. ‡Includes 21 STs that were each unique to a single isolate. §Each of 6 FR isolates harbored 2 additional Pdr1 AAS (E340G/D919Y [ST7], Y556C/F580I [ST7], N132S/G1099S [ST7], F832L/L833V [ST3], G189V/E340G [other ST], and L366P/E555D [other ST]). ¶Two F-SDD isolates harbored additional Pdr1 AAS (V502I [ST55] and R250K [other ST]).
1These first authors contributed equally to this article.
Page created: January 04, 2021
Page updated: March 01, 2021
Page reviewed: March 01, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.